title: The impact of human ABO blood groups on human xenoreactive antibody-mediated cytotoxicity and the protective effect of human decay-accelerating factors exogene on swine endothelium.
abstract: Swine tissue can express antigens similar to human A/B blood types. We evaluated whether the variation in human blood type influences the human xenoreactive antibody-mediated cytotoxicity and modifies the protective effect of human decay-accelerating factor (hDAF) exogene, a complement activation regulator, on swine endothelium.
  
  
  METHODS
  Pig aortic endothelial cells were harvested form normal and hDAF transgenic pigs. Cellular viability was evaluated with an MTT assay.
  
  
  RESULTS
  As compared with that of other human blood types, human serum from blood type O donors induced more prominent cytotoxicity on swine endothelial cells both from hDAF transgenic or normal pigs (P < .05). In addition, this difference of xenoreactive antibody-induced cytotoxicity between treatment with O and other human blood type sera was more evident in hDAF transgenic swine endothelial cells than those of normal pigs (P < .05). The hDAF exogene can significantly protect the endothelial cells from human xenoreactive antibody-mediated cytotoxicty when treated with human serum from AB blood type (P < .05). Our data demonstrated that human ABO blood type significantly affected human xenoreactive antibody-induced cytotoxicity, which may modulate the protective effect of hDAF exogene expression on swine endothelial cells.
authors: Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
authors: J M
authors: JM
authors: Lee
authors: C F
authors: CF
authors: Tu
authors: H C
authors: HC
authors: Tai
authors: N K
authors: NK
authors: Chou
authors: C N
authors: CN
authors: Weng
authors: Y C
authors: YC
authors: Lee
authors: P H
authors: PH
authors: Lee
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology*; D018958:CD55 Antigens / Q000235:genetics* / Q000494:pharmacology*; D002470:Cell Survival / Q000276:immunology*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D008954:Models, Biological; D013552:Swine; D014183:Transplantation, Heterologous
chemical_list: D000017:ABO Blood-Group System; D000910:Antibodies, Heterophile; D018958:CD55 Antigens